The 13th International Child Neurology Congress aims to cover all aspects of child neurology and affiliated topics. You are invited to submit abstracts on the following topics. Submissions will be considered for platform and poster presentations. All abstracts are to be submitted online and should be a maximum of 250 words. See detailed author guidelines below
Submissions Open May 1, 2013
Submissions Close Dec 1, 2013
- Cerebral Palsy
- Neurodevelopmental disabilities
- CNS infection
- Development, cognition and neuropsychiatry
- Education and training
- Metabolic Disorders
- Movement Disorders
- Muscle and Nerve
- Neonatal and fetal neurology
- Neurotrauma, critical care and neuroprotection
- Neurocutaneous and Neurogenetics
- Stroke and Neurovascular disorders
- Neuroethics and History
SUBMITTING AN ABSTRACT
- Once you register with the ICNC site, you may submit more than one abstract. You don't need to separately register for submitting each abstract. Please note that your login/password details is different to your ICNApedia (The ICNA Main Website) login credentials. Even if you have registered with the ICNApedia website, you will still need to register separately for the ICNC2014
- Abstracts are required for all papers and posters.
- Abstracts MUST be submitted ONLINE
- Text must be in single line spacing.The number of words in the abstract is limited to 250
PREPARATION OF YOUR ABSTRACT
A “blind” peer review process will be used. No identifying features such as names of hospitals, medical schools, universities, clinics or cities may be listed in the title or text of the abstract. Do not include the names of authors either. The names of authors and their affiliations (institutions) will be submitted on-line when you submit the abstract.
Abstracts which have been presented to a substantially different audience, especially an local or regional one, may be submitted for consideration.
Abstracts should state briefly and clearly an introduction, methods or description of the case results and discussion points. The maximum word count is 250 words.
Title: The title should be as brief as possible but long enough to indicate clearly the nature of the study.
Introduction: Describe the context of the research/case and explain its relevance and importance
Methods: Concise description of the process by which the research was conducted
Case Description (if applicable): Report the case using the standard medical sequence
Results: The results or outcome of your work. If you don’t have final results yet in time for the abstract submission, you can either include any preliminaryresults that you do have, or you can briefly mention the results that you expect to obtain. Abstracts without any mention of results or indicated "to be confirmed" will not be accepted.
Conclusion/Discussion: Discuss the reasons for particular decisions being made and highlight any important learning points or lessons.
Acknowledgements can be either mentioned in the text of the abstract or separately in the box provided under supporting agencies
Units and Symbols: Metric units according to the System of International Units (SI) should be used.
Equations should use the Equation style, tab centred with the number in parentheses on the right, as shown below.
Abbreviations: Use standard abbreviations. For terms that are abbreviated, use the whole the first time, followed by the abbreviation in parenthesis. Abbreviate journal titles according to Index Medicus and give year, volume number and inclusive pages. Use references sparingly within the body of your abstract.
References: For journals, mention first author "et al" followed by the name of the journal as abbreviated in the Index Medicus, year, volume number and inclusive pages (i.e. Hardus P et al. Epilepsia 2001;42:262-267.). For book chapters, give first author "et al", editor, title, publisher, city of publication, year and inclusive pages (i.e. Levy RH et al. In: Levy RH et al, Antiepileptic Drugs. Lippincott-Raven, 1996;13-30.)
International nonproprietary names and abbreviations for antiepileptic drugs as published in Epilepsia 1993; 34(6):1151, should be used. References for book chapters should consist of editor, title, city of publication, publisher, year and inclusive pages. Non-proprietary names of drugs must be used throughout. If results are considered to be specific for a given proprietary product (for example, bio-equivalence studies), the non-proprietary name must still be used, followed by the proprietary name and the name of the manufacturers in brackets.
Supplementary material: You may upload any supplementary material along with your abstract. The files, which can be in any format, might include (a) research instruments, (b) data sets, which comply with the terms of the study's research ethics review, (c) sources that otherwise would be unavailable to readers, (d) figures and tables that cannot be integrated into the text itself, or other materials that add to the contribution of the work.
Authors are advised that abstracts without an explicit concluding sentence stating the significance of the findings will not be accepted. It is not satisfactory to say the results will be discussed. Case reports are strongly discouraged unless they present very novel and significant findings or potential therapies, as determined by the ICNC Scientfic Program Review Committee.Please include hard data such as the "n" or "p" of observations and statistical values
THE SUBMISSION PROCESS
- Inorder to submitting a new abstract you need to log in to the ICNC2014 website and click on Abstract Submission and follow the instructions.
- You need to register with the site before you can submit an abstract.